Post job

Saol Therapeutics CEO and executives

Executive Summary. Based on our data team's research, David Penake is the Saol Therapeutics's CEO. Saol Therapeutics has 66 employees, of which 12 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Saol Therapeutics executive team is 33% female and 67% male.
  • 64% of the management team is White.
  • 12% of Saol Therapeutics management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Saol Therapeutics?
Share your experience

Rate Saol Therapeutics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
David Penake

Chief Executive Officer

Brian Jennette

Vice President Finance

Brian Nappi

Senior Vice President of Strategy

Melinda Koehler

Vice President of Operations and Compliance

Paul Havenga

Vice President

Sharon Hamm

Senior Vice President of Development

Dever F. Warner

Board Member

James Flexner

Board Member

John Devane

Board Member

Thomas Vandervort

Board Member

Do you work at Saol Therapeutics?

Does leadership effectively guide Saol Therapeutics toward its goals?

Saol Therapeutics jobs

Saol Therapeutics board members

Name & TitleBio
Dever F. Warner

Board Member

James Flexner

Board Member

John Devane

Board Member

Thomas Vandervort

Board Member

Virinder Nohria

Chairman

Saol Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Saol Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Saol Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Saol Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Saol Therapeutics. The data presented on this page does not represent the view of Saol Therapeutics and its employees or that of Zippia.

Saol Therapeutics may also be known as or be related to Saol Holdings LLC and Saol Therapeutics.